RxDoctor Payments Data

Olivia Hubbard

Family · Austin, TXNPI 1982282646

Payments from drug & device makers

$3,921in general payments, 2019–2025

Across 145 payments — averaging $27.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$673
  • Collegium Pharmaceutical, Inc.$618
  • Spinal Simplicity, LLC$442
  • AbbVie$364
  • Boston Scientific$324
  • Pfizer$256
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$3,921100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,921 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl70$60,518
Nurtec OdtRimegepant Sulfate11$19,915
SymproicNaldemedine Tosylate12$10,503
Pregabalin406$7,518
Buprenorphine20$6,782
MovantikNaloxegol Oxalate15$6,059
Tizanidine Hcl256$3,664
Lidocaine14$2,878
Gabapentin158$2,554
Buprenorphine Hcl80$2,547
Methocarbamol72$2,101
Celecoxib88$1,802
Cyclobenzaprine Hcl105$1,741
Duloxetine Hcl56$1,571
Tramadol Hcl137$1,486

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$618$60,51870 claims
PfizerNurtec Odt$256$19,91511 claims
Hikma Pharmaceuticals USABuprenorphine, Buprenorphine Hcl$17$9,329100 claims
Redhill Biopharma Inc.Movantik$14$6,05915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 15,456 family providers in Texas.

Other family in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →